NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Yatharth Hospital & Trauma Care Services Limited (NSE: YATHARTH)
YATHARTH Technical Analysis
2
As on 6th Jan 2025 YATHARTH SHARE Price closed @ 555.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 497.70 & Strong Sell for SHORT-TERM with Stoploss of 618.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
YATHARTHSHARE Price
Open | 570.90 | Change | Price | % |
High | 572.15 | 1 Day | -12.40 | -2.18 |
Low | 550.05 | 1 Week | -2.40 | -0.43 |
Close | 555.50 | 1 Month | -97.85 | -14.98 |
Volume | 575421 | 1 Year | 177.35 | 46.90 |
52 Week High 685.95 | 52 Week Low 312.25 |
NSE INDIA Most Active Stocks
IDEA | 7.88 | -4.72% |
EASEMYTRIP | 16.20 | 4.45% |
YESBANK | 18.90 | -5.31% |
ITI | 544.35 | 19.09% |
GTLINFRA | 1.97 | -2.96% |
SUZLON | 58.85 | -5.00% |
UNIONBANK | 114.72 | -7.53% |
ZOMATO | 264.85 | -2.93% |
JPPOWER | 16.78 | -5.04% |
TATASTEEL | 132.18 | -4.47% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
SPCENET | 12.98 | -20.02% |
JAICORPLTD | 203.00 | -10.00% |
KARMAENG | 70.60 | -9.91% |
BAJAJHCARE | 572.65 | -9.48% |
UNITEDTEA | 515.15 | -9.00% |
ASHOKA | 277.95 | -8.99% |
SINCLAIR | 119.75 | -8.98% |
PRAENG | 29.87 | -8.93% |
SIYSIL | 865.60 | -8.86% |
UMAEXPORTS | 108.80 | -8.81% |
YATHARTH Daily Charts |
YATHARTH Intraday Charts |
Whats New @ Bazaartrend |
YATHARTH Free Analysis |
|
YATHARTH Important Levels Intraday
RESISTANCE | 598.09 |
RESISTANCE | 584.43 |
RESISTANCE | 575.99 |
RESISTANCE | 567.54 |
SUPPORT | 543.46 |
SUPPORT | 535.01 |
SUPPORT | 526.57 |
SUPPORT | 512.91 |
YATHARTH Target January 2025
4th UP Target | 810.47 |
3rd UP Target | 741.26 |
2nd UP Target | 698.47 |
1st UP Target | 655.69 |
1st DOWN Target | 533.61 |
2nd DOWN Target | 490.83 |
3rd DOWN Target | 448.04 |
4th DOWN Target | 378.83 |
YATHARTH Weekly Target
4th UP Target | 671.57 |
3rd UP Target | 638.32 |
2nd UP Target | 617.77 |
1st UP Target | 597.22 |
1st DOWN Target | 538.58 |
2nd DOWN Target | 518.03 |
3rd DOWN Target | 497.48 |
4th DOWN Target | 464.23 |
YATHARTH Target2025
4th UP Target | 1197.65 |
3rd UP Target | 995.28 |
2nd UP Target | 870.2 |
1st UP Target | 745.11 |
1st DOWN Target | 388.19 |
2nd DOWN Target | 263.1 |
3rd DOWN Target | 138.02 |
4th DOWN Target | -64.35 |
Yatharth Hospital & Trauma Care Services Limited ( NSE INDIA Symbol : YATHARTH )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
YATHARTH Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
YATHARTH Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
YATHARTH Address
YATHARTH Latest News
YATHARTH Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service